Our findings highlight that tumor‐informed ctDNA status may provide complementary predictive information beyond PD‐L1 expression in guiding first‐line ICI‐chemo decisions for advanced NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.